Zensun´s rhNRG-1 Project has passed the Preliminary Evaluation by Boehringer-Ingelheim

In April 15, 2003, Boehringer-Ingelheim finished the preliminary evaluation of anti-heart failure drug—rhNRG-1. In late April, more detailed data was provided by Zensun to undergo the second round of evaluation.

The release as fetched from its publisher. zensun.com ↗